Home  |  Contact

Cellosaurus HCC4011/R (CVCL_S747)

Cell line name HCC4011/R
Synonyms HCC4011/ER; HCC4011R
Accession CVCL_S747
Resource Identification Initiative To cite this cell line use: HCC4011/R (RRID:CVCL_S747)
Comments Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
Sequence variations EGFR p.Leu858Arg (c.2573T>G) (from parent cell line).
Disease Lung adenocarcinoma (NCIt: C3512)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_S700 (HCC4011)
Sex of cell Male
Age at sampling 53Y
Category Cancer cell line

PubMed=22773810; DOI=10.1073/pnas.1203530109
Ohashi K., Sequist L.V., Arcila M.E., Moran T., Chmielecki J., Lin Y.-L., Pan Y., Wang L., de Stanchina E., Shien K., Aoe K., Toyooka S., Kiura K., Fernandez-Cuesta L., Fidias P., Yang J.C.-H., Miller V.A., Riely G.J., Kris M.G., Engelman J.A., Vnencak-Jones C.L., Dias-Santagata D., Ladanyi M., Pao W.
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.
Proc. Natl. Acad. Sci. U.S.A. 109:E2127-E2133(2012)

Other Wikidata; Q54881734
Polymorphism and mutation databases Cosmic; 1890458